Filter
1737
Filtered Results: 1737
Text search:
National
Medicines
Regulatory
Authority
Featured
Recommendations
164
New Publications
481
Language
Document type
No document type
833
Studies & Reports
330
Guidelines
290
Manuals
119
Strategic & Response Plan
104
Fact sheets
25
Situation Updates
15
Training Material
12
Resource Platforms
4
Brochures
3
Infographics
1
Online Courses
1
Countries / Regions
Global
70
Kenya
65
India
60
Ethiopia
49
Uganda
37
Nigeria
35
South Africa
35
Liberia
34
Western and Central Europe
33
Tanzania
29
Ghana
28
Zambia
28
Sierra Leone
26
Africa
25
Ukraine
24
Nepal
23
Latin America and the Carribbean
23
South–East Asia Region
21
Bangladesh
21
Rwanda
20
Malawi
18
Eastern Europe
17
Myanmar / Burma
15
Syria
13
West and Central Africa
13
Namibia
13
Lesotho
12
Zimbabwe
12
Philippines
12
East and Southern Africa
11
Guinea
9
Eswatini/ Swaziland
9
Asia
8
Middle East and North Africa
8
Cambodia
7
Botswana
7
Congo, Democratic Republic of
6
Indonesia
6
Mozambique
5
USA
5
Eastern Europe and Central Asia
5
Sudan
5
Pakistan
5
Senegal
4
Jordan
4
Western Pacific Region
4
North America
4
Moldova
4
Georgia
4
Somalia
4
Tajikistan
3
Thailand
3
Benin
3
Cameroon
3
Albania
3
Laos
3
Burkina Faso
3
Afghanistan
3
Haiti
3
Germany
3
Iran
2
Peru
2
Turkmenistan
2
Bosnia and Herzegovina
2
Lebanon
2
Vietnam
2
Papua New Guinea
2
Russia
2
South Sudan
2
Ecuador
2
North Macedonia
1
Colombia
1
Timor Leste/ East Timor
1
Turkey
1
Australia
1
Kazakhstan
1
Chile
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Morocco
1
Qatar
1
Saudi Arabia
1
Paraguay
1
Gabon
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Belarus
1
Bolivia
1
Brazil
1
Sri Lanka
1
Egypt
1
Greece
1
Palestine
1
Mali
1
Chad
1
Libya
1
Iraq
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
648
Clinical Guidelines
145
Public Health
123
Women & Child Health
67
Key Resources
67
Pharmacy & Technologies
50
Capacity Building
10
Toolboxes
AMR
146
COVID-19
121
Pharmacy
120
HIV
119
TB
103
Mental Health
70
Rapid Response
63
Planetary Health
61
Caregiver
55
Global Health Education
37
Ebola & Marburg
36
NTDs
31
NCDs
29
Conflict
28
Disability
20
Specific Hazards
19
Health Financing Toolbox
18
Refugee
16
Natural Hazards
15
Zika
9
Polio
8
Malaria
6
Cholera
4
Social Ethics
2
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...
This quick guide offers basic information about COVID-19, the Sinovac-CoronaVac COVID-19 vaccine and what to
expect following vaccination: ...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
This report describes the activities of the WHO European Centre for Primary Health Care in 2022.The Centre accelerated face-to-face country support after the wake of the COVID-19 pandemic to support countries in engaging in analysis and diagnosis, developing strategies and policies, building capacit...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 progress
Special Report
Accessed: 07.11.2019
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a comprehensive strategy to address the global rise in noncommunicable diseases (NCDs), including cardiovascular diseases, cancer, chronic respiratory diseases,...
28 Dec 2020. The main objective of these guidelines is to provide tools for staff working in the field of immunization to support effective communication between health personnel and the general population, with the aim of strengthening, maintaining or recovering trust in vaccines and the immunizati...
Successful detonation of an improvised nuclear device (IND) would be a catastrophic event, causing an unprecedented number of injuries and lives lost, as well as economic, political, and social disruption. However, an effective medical response and an infrastructure prepared to protect itself from f...
Alcohol consumption is deeply embedded in the social landscape of many societies. Several major factors have an impact on levels and patterns of alcohol consumption in populations – such as historical trends in alcohol consumption, the availability of alcohol, culture, economic status and trends i...
Emerging evidence and experience to inform risk management in a warming world
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R...
A framework for planning, developing and implementing solutions with and for young people.
The guidance presented in this document is intended for digital health intervention designers, developers, implementers, researchers and funders. Newcomers to digital health can use it as a start-to-finish pr...
WHO recommendations on adolescent health: guidelines approved by the WHO Guidelines Review Committee
This document is meant to respond to the questions:
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
The primary audience for this guidance is persons
working directly in vector-borne disease prevention
and control, including programme managers,
researchers and field workers. A brief technical
background is provided for the benefit of persons
without expertise in vector-borne diseases; readers...
